Patents by Inventor Philippa Jane Webster

Philippa Jane Webster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10077466
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to improved, stable nanoreporter probes that are capable of binding to and identifying target molecules based on the probes' uniquely detectable signal. Methods for identifying target-specific sequences for inclusion in the probes are also provided, as are methods of making and using such probes. Polynucleotide sequences of certain nanoreporter components are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Grant
    Filed: March 28, 2016
    Date of Patent: September 18, 2018
    Assignee: NanoString Technologies, Inc.
    Inventors: Philippa Jane Webster, Timothy Dahl
  • Publication number: 20180135099
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to coded, labeled probes that are capable of binding to and identifying target molecules based on the probes' label codes. Methods of making and using such probes are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Application
    Filed: January 2, 2018
    Publication date: May 17, 2018
    Inventors: Gary K. GEISS, Sean M. FERREE, Philippa Jane WEBSTER, Krassen M. DIMITROV
  • Publication number: 20180066309
    Abstract: The invention provides compositions and methods for the detection of gene copy number and/or chromosome copy number in a multiplexed reaction. The assays and kits described herein are applicable for the identification, diagnosing, and monitoring of disorders including, but not limited to cancer, developmental and degenerative disease, neurological disorders, and stem cell disorders.
    Type: Application
    Filed: October 10, 2017
    Publication date: March 8, 2018
    Inventors: Paul Nevin Hengen, Gary K. Geiss, Nathan Elliott, Philippa Jane Webster
  • Patent number: 9890419
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to coded, labeled probes that are capable of binding to and identifying target molecules based on the probes' label codes. Methods of making and using such probes are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: February 13, 2018
    Assignees: NanoString Technologies, Inc., The Institute for Systems Biology
    Inventors: Gary K. Geiss, Sean M. Ferree, Philippa Jane Webster, Krassen M. Dimitrov
  • Patent number: 9856519
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to improved, stable nanoreporter probes that are capable of binding to and identifying target molecules based on the probes' uniquely detectable signal. Methods for identifying target-specific sequences for inclusion in the probes are also provided, as are methods of making and using such probes. Polynucleotide sequences of certain nanoreporter components are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Grant
    Filed: March 28, 2016
    Date of Patent: January 2, 2018
    Assignee: NanoString Technologies, Inc.
    Inventors: Philippa Jane Webster, Timothy Dahl
  • Patent number: 9758834
    Abstract: The application describes methods for diagnosing subjects with leukemia by detecting fusion genes associated with the onset of leukemia.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: September 12, 2017
    Assignee: NanoString Technologies, Inc.
    Inventors: Philippa Jane Webster, Richard Kemble Boykin, Jeannette Nussbaum
  • Publication number: 20160273026
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to improved, stable nanoreporter probes that are capable of binding to and identifying target molecules based on the probes' uniquely detectable signal. Methods for identifying target-specific sequences for inclusion in the probes are also provided, as are methods of making and using such probes. Polynucleotide sequences of certain nanoreporter components are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Application
    Filed: March 28, 2016
    Publication date: September 22, 2016
    Inventors: Philippa Jane WEBSTER, Timothy DAHL
  • Publication number: 20160265025
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to coded, labeled probes that are capable of binding to and identifying target molecules based on the probes' label codes. Methods of making and using such probes are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Inventors: Gary K. GEISS, Sean M. FERREE, Philippa Jane WEBSTER, Krassen M. DIMITROV
  • Publication number: 20160201120
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to improved, stable nanoreporter probes that are capable of binding to and identifying target molecules based on the probes' uniquely detectable signal. Methods for identifying target-specific sequences for inclusion in the probes are also provided, as are methods of making and using such probes. Polynucleotide sequences of certain nanoreporter components are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Application
    Filed: March 28, 2016
    Publication date: July 14, 2016
    Inventors: Philippa Jane WEBSTER, Timothy DAHL
  • Patent number: 9376712
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to improved, stable nanoreporter probes that are capable of binding to and identifying target molecules based on the probes' uniquely detectable signal. Methods for identifying target-specific sequences for inclusion in the probes are also provided, as are methods of making and using such probes. Polynucleotide sequences of certain nanoreporter components are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Grant
    Filed: August 1, 2013
    Date of Patent: June 28, 2016
    Assignee: NanoString Technologies, Inc.
    Inventors: Philippa Jane Webster, Timothy Dahl
  • Patent number: 9371563
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to coded, labeled probes that are capable of binding to and identifying target molecules based on the probes' label codes. Methods of making and using such probes are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: June 21, 2016
    Assignees: NanoString Technologies, Inc., The Institute for Systems Biology
    Inventors: Gary K. Geiss, Sean M. Ferree, Philippa Jane Webster, Krassen M. Dimitrov
  • Publication number: 20140017688
    Abstract: The application describes methods for diagnosing subjects with leukemia by detecting fusion genes associated with the onset of leukemia.
    Type: Application
    Filed: March 28, 2012
    Publication date: January 16, 2014
    Applicant: NANOSTRING TECHNOLOGIES, INC.
    Inventors: Philippa Jane Webster, Richard Kemble Boykin, Jeannette Nussbaum
  • Publication number: 20140005067
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to improved, stable nanoreporter probes that are capable of binding to and identifying target molecules based on the probes' uniquely detectable signal. Methods for identifying target-specific sequences for inclusion in the probes are also provided, as are methods of making and using such probes. Polynucleotide sequences of certain nanoreporter components are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Application
    Filed: August 1, 2013
    Publication date: January 2, 2014
    Inventors: Philippa Jane Webster, Timothy Dahl
  • Publication number: 20130230851
    Abstract: The present invention relates to compositions and methods for detection and quantification of individual target molecules in biomolecular samples. In particular, the invention relates to coded, labeled probes that are capable of binding to and identifying target molecules based on the probes' label codes. Methods of making and using such probes are also provided. The probes can be used in diagnostic, prognostic, quality control and screening applications.
    Type: Application
    Filed: March 11, 2013
    Publication date: September 5, 2013
    Applicants: THE INSTITUTE FOR SYSTEMS BIOLOGY, NANOSTRING TECHNOLOGIES, INC.
    Inventors: Gary K. Geiss, Sean M. Ferree, Philippa Jane Webster, Krassen M. Dimitrov